Sprinter and marathoner CAR T cells reveal their distinct cancer-killing behavior
The study lays a foundation for designing CAR molecules that maximize antitumor activity beyond B cell malignancies.
Read MoreThe study lays a foundation for designing CAR molecules that maximize antitumor activity beyond B cell malignancies.
Read MoreResearchers relate their journey to finding a promising method to address CAR T cell challenges in treating solid tumors.
Read MoreThe team integrated proteogenomic datasets of more than 1,000 tissue samples spanning 10 cancer types to illuminate protein targets for cancer therapy.
Read MoreDetailed molecular characterization of endometrial carcinomas identifies potential markers for guiding more precise treatment.
Read MoreThe findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read MoreA Baylor College of Medicine-Rice University collaboration is making strides in the treatment of mesothelioma and other cancers.
Read MoreA metabolic vulnerability in neuroblastoma could be exploited to overturn these tumors’ resistance to therapy.
Read MoreA phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read MoreThe findings support a diagnostic algorithm to identify the cancer subtype and guide specialized treatment.
Read MoreBy taking a close look inside mesothelioma, Dr. B. Burt searches for clues to predict patient’s response to immunotherapy.
Read More